Not everyone is convinced. Short-sellers warn that biotech companies like Beam face steep financial challenges. Jim Chanos, known for spotting overvalued stocks, believes ARK often gets caught up ...
What risks does Beam face in its clinical development programs? Beam’s reliance on novel base editing technology introduces inherent risks in its clinical development programs. The long-term ...
Moksha Beam is an innovative smoking cessation tool ... common psychological challenge of oral fixation that many smokers face. Its unique shape provides a comforting familiarity, allowing users ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback